Post-earnings recap
Reported
Mon, Aug 12, 2024
EPS actual
$-0.60
EPS est.
$-0.38
EPS surprise
-58.73%
1-day move
-2.17%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Immunome Inc's earnings report indicates a significant miss on EPS, which has contributed to a 2.17% decline in stock price. The lack of revenue figures and guidance leaves investors uncertain about the company's immediate future. Management's defensive tone suggests that they are aware of the challenges ahead but are focused on addressing them.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.60 | N/A | -58.73% |
| Revenue | N/A | N/A | N/A |
Management acknowledged the difficulties faced in the quarter and emphasized a commitment to overcoming these challenges. They did not provide specific guidance for the upcoming periods.
Management expressed concerns about ongoing challenges in meeting financial expectations.
The team is focused on addressing operational hurdles to improve future performance.